Imvax combination immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Imvax combination immunotherapy, covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma [Phase 2]